semaglutide news november 28 2025 Insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss CMS Moved to Expand Obesity
Description
S.TencerovaM.FrlichJ.KassemM.FrostM

However, the net outcome of central stimulation leads to more prominent reductions in appetite, blood glucose and body weight in adult females, suggesting that GLP-1 receptor treatments are more effective treatments for diabetes and obesity in females compared to males

Austin closely monitors each patient for safety, tolerance, and progress
Oh, I almost forgot
Here's the uncomfortable truth: up to 25-40% of the weight you lose on GLP-1 medications can be muscle, not fat
But some people may feel uncomfortable or need to stop the medicine if the side effects are serious